|
|
|
|
|
by hirenj
388 days ago
|
|
Not my subject area, but at least one other group looked at ABCA1, and judging from this abstract, it has been linked via GWAS already, and furthermore concludes it doesn’t play a role (I haven’t looked at the data though). I don’t know, but if we were to reframe this as some software to take a hit from a GWAS, look up the small molecule inhibitor/activator for it, and then do some RNA-seq on it, I doubt it would gain any interest. https://iovs.arvojournals.org/article.aspx?articleid=2788418 |
|
Ultimately we want effective treatments but the goal of the assistant isn't to perfectly predict solutions. Rather it's to reduce the overall cost and time to a solution through automation.